Search

Trade Ideas (9)
Date Ticker Price Dir Speaker Thesis Source
Feb 17
HCA
$534.78
$535.02 +0.0%
N/A Finnhub News Finnhub - HCA
Here's How Much $100 Invested In HCA Healthca...
Feb 17
HCA
$534.78
$535.02 +0.0%
N/A Finnhub News Finnhub - HCA
Are Wall Street Analysts Predicting HCA Stock...
Feb 16
HCA
$540.29
$535.02 -1.0%
N/A Finnhub News Finnhub - HCA
HCA Healthcare, Inc.'s (NYSE:HCA) large insti...
Feb 13
HCA
$540.29
$535.02 -1.0%
N/A Finnhub News Finnhub - HCA
1 Unstoppable Healthcare Stock to Buy and Hol...
Feb 12
HCA
$535.22
$535.02 -0.0%
N/A Finnhub News Finnhub - HCA
Tenet Healthcare Beats Q4 Earnings: But 2026 ...
Feb 12
HCA
$535.22
$535.02 -0.0%
N/A Finnhub News Finnhub - HCA
Tenet expects $250M hit from loss of ACA subs...
Feb 12
HCA
$535.22
$535.02 -0.0%
N/A Finnhub News Finnhub - HCA
At US$531, Is HCA Healthcare, Inc. (NYSE:HCA)...
Feb 11
HCA
$531.47
$535.02 +0.7%
AVOID Eric Burlison
Representative (R-MO)
Rep. Burlison discusses the "Khloe Cole Act," which the DOJ helped draft, creating a "private right of action" (ability to sue) for patients to sue doctors and pharma companies for gender-affirming care (puberty blockers/surgeries) with a lengthy statute of limitations. Bondi expresses strong support ("proud to work hand in hand"). This legislation opens a new floodgate of medical malpractice and product liability litigation against hospitals and pharmaceutical companies involved in these treatments. Similar to the opioid crisis, creating a specific legal framework for mass torts against healthcare providers creates unquantifiable liability overhangs for specific hospital chains and drug manufacturers. The legislation may not pass Congress; the number of claimants may be statistically insignificant to large cap pharma earnings. CNBC
Attorney General Pam Bondi testifies before H...
Feb 11
HCA
$531.47
$535.02 +0.7%
LONG Pierre Yared
Economist / Columbia Business School Professor
"82,000 jobs from health care... That's 95% of the jobs that were added... It's a trend that we've continued to see because of demographic changes." The host questions the quality of this growth, but Yared defends it as structurally necessary due to an "aging society." If 95% of labor demand is in this sector, it indicates where revenue and utilization are actually expanding in a slowing economy. LONG. Healthcare providers and services are the only sector showing recession-proof volume growth in this data set. Regulatory changes or reimbursement rate cuts could impact profitability despite high volume. Bloomberg Markets
Yared Praises 'Blowout' Jobs Report, Says Fed...